{"id":"W2586331836","doi":"10.1182/blood.v120.21.202.202","title":"A Phase 2 Study of Elotuzumab (Elo) in Combination with Lenalidomide and Low-Dose Dexamethasone (Ld) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (R/R MM): Updated Results","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Lenalidomide; Dexamethasone; Medicine; Regimen; Population; Phases of clinical research; Internal medicine; Neutropenia; Gastroenterology; Urology; Pharmacology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001717555,0.001017029,0.001589071,0.0004820289,0.0002076939,0.0008097277,0.0007235842,0.0008357339,0.002538888],"category_scores_gemma":[0.0008122845,0.0005020024,0.001377559,0.0005118286,0.0004308205,0.0006697675,0.000325946,0.001824649,0.0005774428],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000747961,"about_ca_system_score_gemma":0.0009610211,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008964296,"about_ca_topic_score_gemma":0.002483516,"domain_scores_codex":[0.9995964,0.0002136502,0.0000303623,0.00005903284,0.00004971585,0.00005083691],"domain_scores_gemma":[0.9994811,0.0001112552,0.0001641438,0.00002939733,0.00003837404,0.0001756465],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6506083,0.03740631,0.02088624,0.001603547,0.005111506,0.0005337304,0.0004248255,0.002583581,0.03265144,0.0002634122,0.0067557,0.2411714],"study_design_scores_gemma":[0.6738076,0.2701578,0.036268,0.0001265328,0.003635484,0.0008350703,0.00009491612,0.001130658,0.003370874,0.0002621798,0.01024867,0.00006210969],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9810297,0.01019366,0.0006375504,0.0008110381,0.0001224902,0.001828118,0.002646064,0.00009352545,0.00263781],"genre_scores_gemma":[0.975983,0.008773929,0.002698668,0.002171037,0.0002524421,0.001745056,0.006017942,0.00004372464,0.002314148],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002538888,"threshold_uncertainty_score":0.00908339,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01907212814409723,"score_gpt":0.2847329702281542,"score_spread":0.265660842084057,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}